Metagenomi Therapeutics, Inc. - COM (MGX) Institutional Ownership

CUSIP: 59102M104

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / COM
Symbol
MGX on Nasdaq
Price per share
$1.41
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,764,212
Total reported value
$10,956,656
% of total 13F portfolios
0%
Share change
+1,360,495
Value change
+$2,079,727
Number of holders
54
Price from insider filings
$1.41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 59102M104?
CUSIP 59102M104 identifies MGX - Metagenomi Therapeutics, Inc. - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 54 institutional investors reported holding 6,764,212 shares of Metagenomi Therapeutics, Inc. - COM (MGX).

Institutional Holders of Metagenomi Therapeutics, Inc. - COM (MGX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,764,212 $10,956,656 +$2,079,727 $1.62 54
2025 Q3 6,000,175 $14,170,933 -$1,224,304 $2.37 57
2025 Q2 6,750,362 $9,989,847 -$3,542,499 $1.48 67
2025 Q1 9,515,509 $13,160,529 -$3,437,465 $1.36 76
2024 Q4 10,727,379 $38,723,693 +$750,752 $3.61 76
2024 Q3 11,662,818 $25,306,458 -$3,651,260 $2.17 65
2024 Q2 12,188,453 $49,568,061 -$9,507,864 $4.08 54
2024 Q1 13,335,479 $140,258,517 +$140,258,517 $10.55 49